Upcoming Events
| Meet Third Rock Ventures | ||
|---|---|---|
| Date: | Wed, May 15, 5.00 - 7.00 PM | |
| Description: |
Cannon Room, 1st floor Building C, Harvard Medical School, 240 Longwood Ave, Boston
|
|
 |
|||||||||||||||||||
|
Dear Member, Harvard Biotech Club has recently become a supporter of the upcoming event organised by Sachs Associates who have allocated limited amount of complimentary conference passes for students & academics. Other members will be offered a special discounted rate for either attending or presenting at the event.
TO REGISTER OR EXPRESS INTEREST AND RECEIVE The Sachs Cancer Bio Partnering Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering and investment. There are 9 panels plus Keynote Speeches in the plenary session. In addition, there is a presenting company track where companies can present to an audience of financial and industry investors. This would include both listed and venture backed companies. We expect around 300 delegates. There is an online meeting system with meeting facilities to make the event fully transactional. The conference is free to accredited financial investors. WHY ATTEND? Cutting Edge Program including Keynote Speeches made by:
Topics covered in the forum include:
Confirmed
Speakers & Chairs include:
Confirmed Presenting Companies include: Warm Regards
The Sachs Associates Team To UNSUBSCRIBE click HERE |
|
||||||||||||||||||
Past Events
| Flagship Ventures Entrepreneurial Fellows Program Discussion | ||
|---|---|---|
| Date: | Mon, Mar 18, 5.30 - 7.30 PM | |
| Description: |
Cannon Room, 1st floor Building C, Harvard Medical School, 240 Longwood Ave, Boston
|
|
|
Lunch Panel on Business Industries with
Harvard Business School Career Coaches | |
|---|---|
| Date: | Mon, Mar 4, 12-1 PM |
| Description: |
Bray Room, 1st floor New Research Building (next to cafeteria), Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map)
Co-hosted by the
Harvard Graduate Business Club and the Harvard Biotech Club
Come have lunch at the NRB this
coming Monday! We have a lunch panel on business careers by coaches from the
Business School.
|
|
Talk by Biotech Journalist Adam Feuerstein: "Identifying Biotechs that may be Headed for a Takeoff...or a Crash Landing: Lessons for New Investors" | |
| Date: | Tue, Dec 11, 6-7 PM |
| Description: |
Bray Room, 1st floor New Research Building (next to cafeteria), Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map)
We are honored to have invited Adam Feuerstein, senior columnist at TheStreet and one
of today's top biotechnology journalists to
speak to us at the Harvard Biotech Club (http://www. Are you interested in the world of biotech companies and biotech stocks, R&D, clinical trials, and how CEOs manage their companies? From the perspective of one of the most controversial and respected biotech journalists of our times? Join us to learn more! We will start with a 30min talk by Adam, followed by a 30min Q&A session opened to the audience. Read more about Adam Feuerstein on his blog here: http://www.thestreet.com/topic/45381/adam-feuersteins-biotech-blog.html Please RSVP to thebiotechclub.rsvp@gmail.com.
|
|
HIV Competitive Landscape - from science to bedside to biotech | |
|---|---|
| Date: | Mon, Nov 19, 4-5 PM |
| Description: |
Cannon Room, Building C, HMS Quad
Dinner reception
following, 5-6 PM
What are the driving factors shaping current drugs for curing HIV? Join us to learn insider secrets on the interplay between scientific ideas, R&D, market dynamics, and the clinical needs of patients.
Dr.
Peter Kolchinsky, Managing Director of the investment fund RA Capital, will
first present a detailed review of the current and future therapeutic
landscape surrounding HIV and chronic disease management.
Presented by
Managing Director - RA Capital
Panel Discussion
Professor of Medicine -
Infectious Disease
Associate Professor at Ragon Institute of MGH, MIT and Harvard Massachusetts General Hospital
Associate Medical Director at Vertex Pharmaceuticals Instructor at Harvard Medical School
|
|
Smooth Transitions: The Top 10 Questions Scientists Ask about Finding an Industry Job | |
|---|---|
| Date: | Tue, Nov 13, 5-6 PM |
| Description: |
Cannon Room, Building C, HMS Quad Dinner reception following, 6-7 PM
This event will
be a one-hour presentation by Dr. Joanne Kamens (see bio below) with
detailed tips, resources and ideas for being successful in a career
transition to industry, followed by a reception. These days, staying in
academia is really the “alternative” career for scientists. The majority of
young scientists will not end up in a traditional academic research
position. This presentation will give you some criteria to consider in
deciding if embarking on an industry science career is right for you and
then will provide concrete tools and resources for preparing for this
transition. An RSVP is required: https://docs.google.com/spreadsheet/viewform?formkey=dGt5OG5RbkFBTmxwQjJoSndtcmlNSHc6MQ
Speaker Bio:
|
Making the Most of
the Harvard Biotechnol
| |
|---|---|
| Date: | Thur, September 13 2012 |
| Description: |
Time: 2:30 - 4:00 PM Venue: Cannon Room, 1st Floor Building C, Harvard Medical School Quad.
Are you attending the
Harvard Biotech Career
Fair on Sep 25? Make the most out of this great opportunity to meet with
employers who want to hire PhDs!
|
| Harvard Biotech Career Fair 2012 | |
|---|---|
| Date: | Tue, Sep 25, 2012 |
| Description: |
Time: 1.00 - 5.00PM Venue: 3rd Floor Rotunda, New Research Building, Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map)
See our
Career Fair website
|
| Symposium on Scientist-Entrepreneurs in Harvard | |
|---|---|
| Date: | Tues, July 17 2012 |
| Description: |
Time: 5:00 - 7:00pm Change in Venue: Cannon Room, Building C, HMS Quad
Have you ever dreamed of turning your scientific research into life-saving drugs some day? Are you a scientist who is aspiring to make a break into entrepreneurship? Do you want to create or be involved in your own biotech startup? Come join the Harvard Biotech Club for a symposium on this amazing career trajectory. Take this opportunity to learn from and network with 3 leading scientist-entrepreneurs in Harvard Medical School. Dr. David Sinclair, Professor of Genetics at Harvard Medical School, Venture Partner at Lux Capital, and co-founder of Sirtris (acquired by GSK for $720M in 2008), Genocea, and now OvaScience.
Dr. Chiang J. Li, Founder, Chairman, Chief Executive Officer, and Chief Medical Officer of Boston Biomedical - recently acquired by Dainippon Sumitomo with an upfront payment of $200M and potential milestone payments totalling up to $2.6B. He also serves as co-Director of the Skip Ackerman Center for Molecular Therapeutics at Beth Israel Deaconess Medical Center, Harvard Medical School. Formerly, Dr. Li was the Chief Scientific Officer & Executive Vice President of ArQule. He has also served as co-founder of Cyclis Pharma (acquired), ArQule Oncology (Nasdaq:arql), and Cequent Pharma (acquired). Dr. Li has over 60 inventions and has translated a number of his medical innovations to patients for the treatment of cancer, and other life threatening disorders.
Dr. Gregory Verdine, Professor of Chemistry at Harvard University, Venture Partner at Third Rock Ventures, and co-founder of Gloucester, Enanta, Tokai, Aileron, Eleven Bio, ONTorii, and now WarpDrive Bio (launched in 2012 with $125M in financing).
This event is open to all Harvard-affiliated students and postdocs. Pizza
will be served. Please RSVP to thebiotechclub.rsvp@gmail.
|
| Healthcare Consulting Panel | |
|---|---|
| Date: | Thurs, July 19th 2012 |
| Description: |
Time: 6.00 - 8.00 PM Venue: Cannon Room, Bldg C, Harvard Medical School, 240 Longwood Ave, Boston MA 02115
Are you interested in a career in consulting, and want to know what consultants actually do and what their life is like? Or will you be on job market soon and would like to know how to be competitive in applying for consulting jobs? If you are either of the above, this is a wonderful opportunity for you! Come join us for a consulting panel discussion this summer. Take this opportunity to talk to consulting professionals from 5 leading firms during the networking session. Companies participating:
McKinsey & company BCG Clarion Healthcare ClearView Healthcare Partners Decision Resources
This event is open to all Harvard- affiliated students and postdocs. Food will be served. Please RSVP to thebiotechclub.rsvp@gmail.com with the title "rsvp for consulting panel".
|
| Massachusetts Life Sciences Innovation Day 2012 | |
|---|---|
| Date: | Wed, May 30 2012 |
| Description: |
Time: 8 am - 7 pm Venue: Harvard Club of Boston, 374 Commonwealth Avenue, Boston
The 5th Massachusetts Life Sciences
Innovation (MALSI) Day is the biggest day for life sciences
startups and innovation in the Commonwealth of Massachusetts. This is a
high-energy, hands-on event which brings together scientific leaders and
business experts to mingle with innovators, post-docs, professors,
entrepreneurs, innovators, and venture capitalists.
May 30, 2012 8:00 a.m. - 7:00 p.m.
EMERGING TECHNOLOGY POSTER SESSION The Search for Proof Poster Competition - great prizes for 3 best posters! A key goal of the event is an exchange of ideas, to connect the broader scientific community with those working in finance and policy. The earliest insight can, in time, foster an entire industry. Our poster session will showcase fundamental advances in research so they can be seen by a broader audience, to help set the compass for where the industry could go in the future.
To reflect the Conference theme "Burden of proof" presenters can include in their posters what has already been proven and what needs to be proven.
If your lab or company has notable discoveries or new grant awards that you want to publicize to the Massachusetts research and business communities please download the application to exhibit a poster and submit it to jgoldberg@umassp.edu by (NOTE DEADLINE EXTENSION) May 22, 2012.
|
| Historical Case Study of Athersys (ATHX) with biotech hedge fund RA Capital | |
|---|---|
| Date: | Thurs, May 24 2012 |
| Description: |
Time: 5:30-8:30pm Venue: TBA only to RSVPs
We are very fortunate to have invited Dr. Peter Kolchinsky, Managing Director, TechAtlas and RA Capital Management, and Mr. Rajeev Shah, Partner, RA Capital Management, to come teach us the thought processes that went into the analysis of a biotech firm's competitive landscape. Come see how its done from the perspective of two very seasoned and successful biotech hedge fund managers. We will do this with a case study on Athersys, a biotech which terminated its obesity drug program to bring forward its mesenchymal stem cell program, in comparison to Arena (obesity drug competitor), Mesoblast and Osiris (stem cell competitors).
"...be prepared for a discussion of investing game theory unlike anything you will get in business school." -- Dr. Peter Kolchinsky |
| Women in Biotech | |
|---|---|
| Date: | Thurs, March 22, 2012 |
| Description: |
Correction: 5:00 PM – 6:30 PM Fred S. Rosen Lecture Hall 100A (Modell Immunology Center, inside the Armenise building at 200 Longwood Avenue, Boston MA 02115)
Keynote Speaker: Daphne Zohar, Founder and Managing Partner, Puretech Ventures
Panelists: Jessica Flechtner (VP of Research, Genocea)
Mari Anne Snow, AWIS
Come and meet distinguished women leaders in the biotech industry and learn about their path to success, what they have learned, and how they have balanced their personal lives with their careers. Our stellar group of panelists includes a venture capitalist, biotech entrepreneurs, and executive leaders from biotech/pharma companies.
Men are invited and encouraged to attend!
A light dinner will be served.
Speaker Bios
Daphne Zohar Daphne Zohar is the founder and managing partner of PureTech Ventures, a Boston-based venture creation firm specializing in translating breakthrough research from top tier academic institutions into therapies that will impact human health. In 2010, Ms. Zohar was recognized by Fierce Biotech as one of the "Top 10 Women in Biotech”, by BioWorld as one of 28 leaders predicted to be the "movers and shakers" of the biotechnology industry over the next twenty years, and by the Boston Globe as one of the "Top 15 Innovators." A successful entrepreneur, Ms. Zohar created PureTech and assembled a leading team to help implement her vision for the firm. She sits on the Boards of Directors of PureTech Ventures, and several companies including Enlight Biosciences, Follica Inc., Libra Biosciences, Vedanta Bioscience, Mandara Sciences (where she is Founding CEO), Karuna Pharmaceuticals, Tal Medical, and Satori Pharmaceuticals. She also sits on the Technology Development Fund Advisory Board at Children's Hospital Boston and is an Editorial Advisor to Xconomy, a national technology news blog. Todd Milne Dr. Todd Milne, is the founder of Ironwood Pharmaceuticals, an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. He has provided scientific management leadership since Ironwood’s founding in 1998, and has been vice president of biology since October 2001. Previously, Dr. Milne was a fellow at Whitehead Institute for Biomedical Research. Dr. Milne’s research has earned him numerous awards and acknowledgements including fellowships from Merck and the Damon Runyon-Walter Winchell Cancer Research Fund. He earned a B.S. in molecular biophysics and biochemistry from Yale University and holds a Ph.D. in microbiology and molecular genetics from Harvard Medical School. Jill Milne Dr. Jill Milne is the co-founder and CEO of Catabasis, a private, venture-backed biopharmaceutical company focused on creating new medicines for the treatment of inflammatory and metabolic diseases. She also serves on the company's board of directors. Prior to Catabasis, Dr. Milne worked at Discovery Biology and was part of the founding team at Sirtris Pharmaceuticals. Prior to Sirtris, Dr. Milne was the worldwide head of the Drug Pfinder Program at Pfizer Global Research and Development. As head of this global program, she was responsible for identifying and evaluating opportunities across all of Pfizer's therapeutic areas of interest. Additionally, Dr. Milne was the head of the Enzyme Target Group at the Pfizer Discovery Technology Center in Cambridge, Mass., where she directed a portfolio of projects from idea stage to proof-of-concept and integration into therapeutic areas across global Pfizer. Prior to joining Pfizer, she was an American Cancer Society postdoctoral fellow in the department of biological chemistry and molecular pharmacology at Harvard Medical School. Dr. Milne holds a Ph.D. from Harvard University and a B.A. in biological chemistry from Wellesley College.
Theresa Podrebarac Dr. Theresa Podrebarac is the VP of Medical Research in Immunology at Biogen Idec. Prior to joining Biogen, she was the VP and global head of Rheumatology Clinical Development at EMD Serono, Inc., and the VP of clinical development at CombinatoRx and at Acceleron Pharma. Prior to joining Acceleron, Dr. Podrebarac served as a Medical Director of Clinical Development at Biogen Idec. She was responsible for Rituxan Phase 3 and Amevive Phase 2 clinical trials in arthritis. In addition, she introduced two new products into the clinic and played a critical role in the Tysabri BLA filing. Dr. Podrebarac is board certified in both Internal Medicine and Rheumatology and holds active appointments at Harvard Medical School and Brigham and Women’s Hospital. Dr. Podrebarac received her medical degree from the University of Western Ontario and completed her post-doctoral training and graduate studies in Immunology at Harvard University. Jessica Flechtner Dr. Jessica Flechtner is the VP of Research at Genocea Biosciences, a company focused on developing a new class of human vaccines based on a revolutionary platform for the rapid discovery of antigens that induce T cell immunity. Prior to joining Genocea, Dr. Flechtner was an Immunology Consultant at Biovest International, where she guided the development of assays to evaluate the success of the company’s autologous Follicular (Non-Hodgkin's) Lymphoma vaccine in patients. As a researcher at Mojave Therapeutics, Inc. and Antigenics Inc., which acquired Mojave's intellectual property, Dr. Flechtner developed protein and peptide-based vaccines and immunotherapies for cancer, infectious disease, autoimmunity and allergy. She is an inventor on nine pending or issued patents and has multiple peer-reviewed scientific publications. Dr. Flechtner performed her post-doctoral work in the laboratory of Dr. Harvey Cantor at the Dana Farber Cancer Institute and Harvard Medical School and holds a Ph.D. in Cellular Immunology and B.S. in Animal Science from Cornell University. She is a member of the American Association of Immunologists and the American Association for Cancer Research. Mari Anne Snow Mari Anne Snow is an organizational development and change management professional with over 20 years experience utilizing technology to support non-disruptive change. She is CEO of SophiaThink, a management consulting firm that helps clients develop high performing virtual teams using new technologies. Before SophiaThink, Mari Anne held senior positions as a business technologist and organizational development professional at the State Street Corporation. Mari Anne is an Adjunct Professor at Bentley University; on the Board of Directors of WEST, a non-profit dedicated to the advancement of women in science and technology; and a contributor to Data Guidance, an international privacy publication. She is also the resident social media guru for Patricia Raskin’s radio show – Positive Business on Rhode Island’s WPRV AM790.
|
| Genentech Day | |
|---|---|
| Date: | Wed, March 21, 2012 |
| Description: |
4:00 pm - 5:30 pm (Pizza will be provided!) Bray Room, NRB
Agenda: 4:00 - 5:00 pm - Corporate presentation and Genentech employee speakers 5:00 - 5:30 pm – Networking session.
Do you want to know why Genentech has been voted one of the Best Places to Work by The Scientist as well as Top Employer by Science Magazine?
Do you want to learn more about both research-related and business-related internships and job opportunities at Genentech?
Do you want to learn how to shape your graduate career for a future in one of the biotech industry’s leading companies?
Then come to GENENTECH DAY to learn about the company & network with recruiters as well as industry leaders!
Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 35 years, using human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions. Today, Genentech is among the world's leading biotech companies, with multiple products on the market and a promising development pipeline. Genentech, one of Forbes Top 100 Best Companies to work in for the 14th year, is coming to Harvard. Genentech recruiters and employees will discuss their unique company culture, opportunities for upcoming internships as well as how to use your degree in the industry. Join HBC for this exciting event!
Registration: Space
is limited to current first and second year Harvard graduate students. To
RSVP, send an email to
rsvp@thebiotechclub.org with |
| Patent Law info-course | |
|---|---|
| Date: | Thursdays, Mar 1, 8, 15, 22 |
| Description: |
Time: 4:30-6:30pm Venue: TMEC 109
For those who hope that the end of their graduate studies also means the end of the latex gloves’ itch and the sore thumb resulting from endless pipetting, this is for you:
In collaboration with Clark & Elbing, LLP, a Boston-based intellectual property law firm, The GSAS Harvard Biotech Club & DMS Law PATH is organizing a 4-week Patent Law info-course for Harvard affiliated students and postdocs.
Please
register here
https://docs.google.com/
Brief Syllabus: Class 1: Introduction to the patent system and patents in general Class 2: Discussion on two court cases Class 3: Drafting claims of a patent application Class 4: Conducting a Freedom to Operate Search and Validity analysis
|
|
Charting a Complex World: How TechAtlas and RA Capital Identify Investment Opportunities (TechAtlas is now recruiting analysts) | |
|---|---|
| Date: | Thursday Dec 8th, 2011 |
| Description: |
Time: 5:30 – 7:30 pm Venue: Goldenson Building Rm 122, Harvard Medical School, 220 Longwood Ave, Boston (next to Courtyard Cafe; HMS campus Map)
Speaker: Peter Kolchinsky, PhD. Managing Director, TechAtlas and RA Capital Management, Graduate of DMS/Virology (Sodroski Lab), co-founder of Harvard Biotech Club
Food will be provided.
TechAtlas is a healthcare strategy and competitive analysis research group recently spun out of RA Capital, a healthcare-focused fund that has successfully invested in public and private drug, diagnostic, and device companies over the last 10 years. TechAtlas’ purpose will be to conduct the kind of research and competitive analysis of different companies/products that RA Capital has been doing since 2002 but now for the benefit of biotech and pharma companies.
Come to this event to meet our team and learn about how we consume massive amounts of data about thousands of technologies by speaking with physicians and company management teams as well as attending scientific, medical, and investor conferences to create “atlases” that highlight the products most likely to address important unmet needs.
Ultimately, everyone is an investor – funds invest capital, companies invest their people and money, and people invest their own time and reputations. Even academic researchers need to think in terms of where they want to invest their time and creativity.
TechAtlas maps out competitive landscapes - for example, there are dozens of Hepatitis C (HCV) drugs in development, but only a few are special, so if you are thinking of investing in HCV or considering getting a job at an HCV company, you’ll first want to see which companies are positioned well to win (hint: high-barrier to viral resistance, pan-genotypic activity, oral bioavailability, potent anti-viral activity = nucleotide polymerase inhibitors). We’ll show you our map of the HCV landscape at the event so you see what we mean… as well as maps of oncology, antibiotics, Alzheimer’s, pain, nephrology, etc.
If you find this interesting, bring a resume and apply for one of the open analyst positions at TechAtlas (it’s like getting an MBA in Biotechnology, without the debt).
To learn more: www.techatlasgroup.com and www.racap.com
RSVP: If you would like to attend this event, please send an email to RSVP@thebiotechclub.org with "TechAtlas" in the subject line.
|
| Intellectual Property and Patent Law Panel | |
|---|---|
| Date: | Wednesday Dec 7th, 2011 |
| Description: |
Time: 4:30 – 6:00 pm Venue: Bray Room, New Research Building (NRB)
Tired of pipetting everyday? Looking for opportunities outside academia? Come meet with people that were once on the same page with you! Harvard Biotech Club is proud to present the patent law discussion panel featuring Michael J. Belliveau, Partner at Clark & Elbing, LLP Jo Parente, Legal Hiring Manager at Wolf, Greenfield & Sacks, P.C. Maryanne Trevisan, Shareholder at Wolf, Greenfield & Sacks, P.C. Vivien Tannoch-Magin, Associate at Hamilton, Brook, Smith & Reynolds, P.C. Deniel Lev, Associate at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
*Amy Sanford, assistant director of Harvard University Office of Career Services will moderate the discussion
Pizza will be served! No registration required. - Discover career opportunities at the intersection of science, technology and business strategy - Hear from people that have successful made the career transition outside the academia - Unique chance to learn about patent law firms in Great Boston area and get recruiting tips |
TiECON East 2011
Key Highlights: · Captivating entrepreneurial stories from industry pioneers. · ‘Thursday Night Keynote Panel’ of entrepreneurs from India. · Entrepreneur Forum (E-Forum) to seek advice on business ideas from VCs and industry experts. · Panel Sessions on Technology, Life Sciences and Clean Tech · BootCamp entrepreneurial workshops · Targeted networking sessions at ValueConnect · Banquet Speaker & Dinner
Time:
June 2 (2:00
pm-9:30 pm), June 3 (8:00 am - 9:30 pm) Sponsoring Organization: TiE-Boston
Registration: https://s08.123signup.com/servlet/SignUpMember?P=15219721911422438300&PG=1521972182300 |
|||||||||||||||||||
| Healthcare & Biotech Consulting Panel | |
|---|---|
| Date: | Tuesday May 17th, 2011 |
| Description: |
Time: 5:30 - 7:30 PM Venue: Cannon Room, Bldg C, Harvard Medical School
If you are curious about healthcare/Biotech consulting, come join us for a panel discussion about this exciting career! Take this opportunity to talk to consulting professionals from 7 leading firms during the networkingCompanies participating: Clarion Healthcare Clearview Leerink Swann Consulting Munevar & Associates Scientia Advisors The Kerdan Group Tunnell Consulting: |
| GCC Business Seminar with Prof. Vicki Sato | |
|---|---|
| Date: | Wednesday, May 4, 2011 |
| Description: |
Time: 6 - 7PM Venue: Northwest Building Room B103 (note location change!) (map)The HGCC Business Knowledge Development team is happy to announce the fourth seminar in the new HGCC Business Seminar Series! Professor Vicki Sato, a joint professor in the Harvard Business School and the Molecular and Cell Biology Department will be answering our questions in an interactive discussion about Science and Business in Science-Based Companies. |
| Company Presentation on Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P | |
|---|---|
| Date: | Thursday, March 30, 2011 |
| Description: |
Time: 5.30 - 7.30PM Venue: TMEC 250, Longwood Medical Area, Harvard Medical School, 260 Longwood Ave, Boston Come meet with company representatives and learn about the firm and a career path in Intellectual Property/Patent Law. Harvard PhDs and postdoctoral fellows from biological sciences, engineering, chemistry are all invited to this event. Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. is one of the largest law firms in the world focusing solely on intellectual property law. The firm practices all aspects of U.S. and international patent, trademark, copyright, and trade secret law, including transactions, counseling, prosecution, licensing, litigation, and portfolio management. |
| An Evening with Third Rock Ventures | |
|---|---|
| Date: | Tuesday, March 8, 2011 |
| Description: |
Time: 5.30 - 7.30PM Venue: Goldenson Building Rm 122, Harvard Medical School, 220 Longwood Ave, Boston
The Harvard Biotech Club invites interested students and post-docs to an informative presentation led by one of the Founders of Third Rock Ventures (TRV), a venture capital firm located in Boston and San Francisco.
TRV is focused on launching exceptional life science companies, working in areas of disruptive science to make a difference in the lives of patients. TRV team members will be on-hand to talk about how TRV’s dedicated focus on early stage life science investments, leads to company formation, and share their personal stories of how their individual career path has led them to the venture industry.
|
| Harvard Biotech Club Annual Career Fair 2010 | |
|---|---|
| Date: | Wednesday November 3, 2010 |
| Description: |
Time: 1.00 - 5.00PM Venue: 3rd Floor Rotunda, New Research Building, Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map)
See our
Career Fair website
|
| Making the Most of the Harvard Biotechnology Club's Career Fair: Resumes and Networking | |
|---|---|
| Date: | Tuesday October 19, 2010 |
| Description: |
Time: 2.30-4.00PM Venue: Warren Alpert Building, Room 341
*Note: Due to space limitations, the workshops will be open only to
Harvard-affiliated members.
|
| Decision Resources – Consulting Information Session | |
|---|---|
| Date: | Tuesday September 21, 2010 |
| Description: |
Time: 5.30-7.30PM Venue: Cannon Room, Building C, 240 Longwood Ave, Harvard Medical School
Interested in healthcare consulting?
Decision Resources is hiring for the
summer and full-time!
|
| Healthcare Consulting Panel Discussion and Networking Session | |
|---|---|
| Date: | Wednesday August 18, 2010 |
| Description: | Open to Harvard students & postdocs & affiliates of Harvard teaching
hospitals Harvard Biotechnology Club, Biomedical Graduate Student Organization
and the Harvard Graduate Consulting Club invite you to a Healthcare
Consulting Panel Discussion and Networking Session featuring: 5:30 – 7:00pm - panel discussion with Q&A 7:00 - 8:00pm - networking session
Panelists
Steven Chao is a founding partner at ClearView Healthcare Partners where he has led therapeutic area growth strategy, clinical development strategy, and product launch strategy engagements, as well as due diligence and asset search projects, spanning multiple therapeutic areas. He joins ClearView from Leerink Swann Strategic Advisors, where he was a Vice President. He joined Leerink Swann in 2004 from McKinsey and Company, where he led strategic engagements in the pharmaceutical, biotechnology, payer, and provider industries. He received his M.D. and his Ph.D. from Harvard Medical School. He has published over 20 articles and led neuroscience research in the laboratories of Dr. Lawrence Benowitz and Dr. Jonathan Seidman. He graduated summa cum laude with his B.A. in Biochemistry from Harvard College.
Mike DeRidder is a manager at L.E.K. Consulting, LLC focused in the life sciences practice. He joined the firm in the summer of 2005 and is based in the Boston office. Mike has recently completed projects assessing the landscape of medical technology and devices as well as venture capital investment trends in this area, formulating and assisting with the execution of an M&A strategy for a major pharmaceutical company, and assessing the value of a royalty stream associated with a blockbuster pain therapy. In addition, he has helped to develop a strategic plan for gaining reimbursement approval for a product-specific diagnostic test in schizophrenia and conducted a detailed assessment of potential acquisition candidates in gastroenterology for a large biotechnology company. Before joining L.E.K., Mike received his Ph.D. in Bioengineering at the University of Pennsylvania. In 1999, Mike received a Bachelor of Science in Engineering, majoring in Biomedical Engineering, from Tulane University.
Daniel J. Hawkins is a founding member of Clarion Healthcare Consulting. Mr. Hawkins has over 20 years of experience in healthcare, having worked with companies ranging from global pharmaceutical companies to development stage biotech and device companies, as well as venture capital/private equity firms that invest in the area. He has worked in functional areas from product development through sales, on issues from product acceleration to board-level M&A advice, and in therapeutic areas ranging from oncology to orthopedics. In addition, Mr. Hawkins has extensive depth in managed care and the payer side having worked with health plans such as WellPoint and New York Life, provider groups, such as Fallon Clinic, and retail pharmacies, such as Wal*Mart. Mr. Hawkins also serves as a Director of M|C Communications, the leading medical education company in the US.Prior to founding Clarion, Mr. Hawkins was President of Hawkins Associates, a consulting firm providing advisory services to emerging and mid-cap healthcare companies as well as financial investors. Mr. Hawkins was CEO of a development stage medical device company. He spent his first 10 years at the consulting firm of Corporate Decisions, Inc., where he was partner, co-head of the healthcare practice and elected one of three members of the Management Committee. Mr. Hawkins has an MBA from the Yale School of Management, and an AB in Economics from Princeton University.
Lily Kim is a Consultant at Decision Resources with specific expertise in evaluating emerging therapies and opportunity assessment. Dr. Kim received her Ph.D. in Biomedical Engineering from the Harvard-MIT Division of Health Sciences and Technology at the Massachusetts Institute of Technology and was awarded a Hertz Foundation Fellowship for her graduate work. While at MIT, Lily researched microfluidic control of stem cell environments. Her work has been presented at several conferences, including the International Society for Stem Cell Research, and published in prominent engineering journals. As part of an MIT Sloan School team, she helped assess the commercial opportunity surrounding microfluidic platforms for testing liver toxicity and presented this work at the IdeaStream entrepreneurship conference. She graduated with an S.B. in Electrical Engineering at the Massachusetts Institute of Technology.
Kristin Ciriello Pothier is a vice president leading the Diagnostics and Discovery Tools Practice at Health Advances, a global practice which meshes her consulting and scientific experience to provide results-oriented commercialization strategies for her clients in the biotech and clinical diagnostics sectors, including focus on launch strategy, pricing, and R&D prioritization for novel diagnostics and biotech platforms for the research laboratory, personalized medicine, point-of-care, and mainstream clinical diagnostics. Her clients range from small diagnostics and tools start-ups to the largest public companies and non-profit institutions in the industry. Kristin is a frequent speaker, workshop leader and writer in the diagnostics and life sciences industries, covering topics such as the future of point-of-care platforms, the commercialization of companion diagnostics, and innovations in personalized medicine. Kristin joined Health Advances in 2002 with extensive experience as a research scientist in the diagnostics and drug discovery industries. Prior to joining Health Advances, Kristin focused on diagnostics technology development at Genzyme and genomics research at Genome Therapeutics. She has an undergraduate degree in Biochemistry from Smith College and a Masters degree in Epidemiology, Health Management, and Maternal and Child Health from the Harvard School of Public Health
|
| ||
|---|---|---|
| Date: | Tuesday April 27, 2010 | |
| Description: |
Globalization in Life Sciences, April 27 Come hear about the global revolution in the life sciences industry from eminent panelists with vast international experience spanning Europe, China, India, the Middle East and more. This event will illustrate how governmental policy, culture, and education can influence a country's research and business innovations. Date : April 27th, 2010 (this Tuesday) Time : 5:15pm-6:30 pm Panel 1 : The State of Global R&D in Life Sciences 6:45pm-8:00 pm Panel 2 : Global Life Sciences Start-up Trends Location : Cannon Room, HMS ~Refreshments will be served at the event. ~ Panel #1: The State of Global R&D in Life Sciences This panel will focus on the nature of life sciences R&D in Asia and Europe and how they compare to practices in the US as well as career opportunities outside the US for scientists. The panel will explore the R&D strengths of different countries and the types of global research collaborations that are being set up by companies. Additionally, the panel will also examine how governmental initiatives and policies are fostering the development of R&D practices around the world. Speakers : Sandra Glucksmann, SVP Research at Cerulean Eli de los Pinos, CEO, Aura Biosciences Shiladitya Sengupta, Professor of Health Science & Technology, MIT John Thomson, VP Research, Vertex Pharmaceuticals Xiaolin Zhang, Head of R&D China, Astra Zeneca Moderator: Mark Namchuk, Head of Research, Vertex Pharmaceuticals * Panel #2: Global Life Sciences Start-up Trends
This panel will provide an investment outlook and
operational analysis on the current and future start-up environment in
China, India, Europe, and the Middle East. Specifically, the current
trends and future potential for the emergence of service providers and
fully functioning life sciences companies in different countries around
the world. |
|
| GSAS Harvard Biotechnology Club Spotlight event: Innovations, Entrepreneurship & Development | ||
| Date: | Thursday March 4, 2010 | |
| Description: | GSAS Harvard Biotechnology Club Spotlight event: Innovations, Entrepreneurship & Development
March 4, 2010 515pm -715pm Cannon Room, Bldg C, Harvard Medical School 515 - 550 pm: Talk 1: Prof Iqbal Z. Quadir 550 - 625 pm: Talk 2: Dr. Una Ryan 630-645 pm: Q/A Session/panel discussion 645-715 pm: Networking reception with speakers and social enterprise companies [Seeding Labs, SolSolution, etc] Speakers: UNA RYAN, OBE, PhD, DSc CEO, Diagnostics For All & Research Professor of Medicine at Boston University School of Medicine Dr. Ryan is the current CEO of Diagnostics For All and was formerly the President and CEO of AVANT Immunotherapeutics, Inc., a publicly traded biopharmaceutical company developing vaccines. Dr. Ryan is also Research Professor of Medicine at Boston University School of Medicine and serves on its Board of Visitors. She serves on a number of boards including Waltham Technologies Inc., AMRI Global, IQuum, the Business Advisory Board of BIO Ventures for Global Health, the Scientific Advisory Board of Genocea, Inc. Dr. Ryan holds a Ph.D. in Cellular and Molecular Biology from Cambridge University and an Honorary Doctor of Science Degree from Bristol University in 2009. She was a Howard Hughes Investigator, NIH MERIT Awardee and an Established Investigator of the American Heart Association. Diagnostics for All is a Cambridge based non-profit enterprise fusing biotechnology and microfluidics, dedicated to creating low-cost, easy-to-use, point-of-care diagnostics designed specifically for the 60% of the developing world that lives beyond the reach of urban hospitals and medical infrastructures. Professor George Whitesides and his team at Harvard University have pioneered the technology underlying the devices. IQBAL Z. QUADIR, Director and Founder, MIT Legatum Center for Development & Entrepreneurship & Professor of Practice, MIT Professor Iqbal Z. Quadir is the founder and director of the Legatum Center for Development and Entrepreneurship at the Massachusetts Institute of Technology (MIT) and founder of Grameenphone Limited in Bangladesh. From 2001-2004, Quadir taught at the John F. Kennedy School of Government at Harvard University, focusing on the democratizing effects of technologies in developing countries. In 2005, he moved to MIT where he co-founded the journal Innovations (MIT Press) and founded the Legatum Center for Development and Entrepreneurship. Professor Quadir holds both an MBA and an MA from the Wharton School, University of Pennsylvania, and a BS with honors from Swarthmore College. The Legatum Center for Development and Entrepreneurship was founded on the belief that economic progress and good governance in low-income countries emerge from entrepreneurship and innovations that empower ordinary citizens. The Center administers programs and convenes events that promote and shape discourse on bottom-up development. Moderated by: CROCKER SNOW, Jr. Director, Edward R. Murrow Center for Public Diplomacy at Tufts University Fletcher School of Law and Diplomacy President, The Money Matters Institute (1996-present); President, World Times, Inc (1979-2001); Editor in Chief, The WorldPaper (Boston) (1979-2001); National and Foreign Editor, The Boston Globe (1976-1978); Assistant to the Publisher, The Boston Globe (1976-1978); Chief Foreign Correspondant for East Asia, The Boston Globe (1972-1974); Assistant Managing Editor, The Boston Globe (1970-1971). ~ Presentation will be followed by a networking reception. Food and drinks will be served~ Please RSVP at rsvp@thebiotechclub.org (Appreciated but not required) Questions?: Contact Shaila Rahman, shaila@thebiotechclub.org To learn more about the Harvard Biotechnology Club, visit our Website: www.thebiotechclub.org |
|
| MassCONNECT: promoting life-sciences entrepreneurship in Massachusetts | ||
| Date: | Tuesday January 26, 2010 | |
| Description: | MassCONNECT - leveraging the life sciences ecosystem to catalyze innovation.
Are you interested in starting a life sciences based company, either as a founder or entrepreneur? MassCONNECT can assist you in getting your ideas and technology crystallized into a business opportunity for presentation to the investment community. We are here to help you think about and think through your business opportunity, and most importantly, connect you to the enablers of the biopharmaceutical industry. Why you should use MassCONNECT: v showcase your technology to industry experts comprising biopharmaceutical executives, venture capitalists, and angels; v connect with individuals and teams of mentors who will provide practical advice on how to increase the value of your opportunity; v receive coaching to prepare for investment pitches and develop concise business plans; v connect to resources to improve your idea; v connect you to avenues for financing your technology; v network into business professionals to develop your management team. Presented by Imran Nasrullah, Chief Business Officer of Massachusetts Biotech Council. |
|
| Genentech Day | ||
| Date: | Monday November 9, 2009 | |
| Description: | The GSAS Harvard Biotech Club presents
GENENTECH DAY Date/Time: November 9, 2009; 11am-2pm Location: NRB, Rotunda Tentative agenda: 11am-12:30pm: Genentech presentation/panel. 12:30pm- : Networking lunch Please RSVP at rsvp@thebiotechclub.org. Space is limited to current Harvard & Harvard hospital-affiliates. Do you want to know why Genentech has been voted one of the Best Places to Work by The Scientist as well as Top Employer by Science Magazine? Do you want to learn more about both research-related and business-related job opportunities at Genentech? Are you curious about how the Roche presence will influence research and culture at Genentech? Are you looking for a JOB at this leading biotech firm located at sunny California?? Then come to GENENTECH DAY to learn about the company & network with recruiters as well as industry leaders! As part of Sponsorship event, Genentech leaders in research, commercialization, manufacturing and product development will be coming to the HMS campus for presentation & recruitment. They are extremely excited to meet the Harvard community - and hoping to recruit great talents from here!! Confirmed speakers include: William Annett, MBA: Director of Business Information Management (Commercial Management)
William Annett received his MBA from the Harvard Business School. His career has consisted primarily of senior roles in rapid growth situations in the healthcare industry. For the past 6 years Mr. Annett has worked in various positions at Genentech in San Francisco, CA. As Director of Business Information Management he is responsible for Commercial business intelligence, reporting, and liaison with the internal IT organization. At the current time he is very involved in the integration of Genentech and Roche¡¦s Commercial IT solutions and business processes. This role has also included leading the Commercial Blueprint, one of the largest change initiatives in Genentech¡¦s history. This $150 million effort replaced Sales & Marketing¡¦s outdated legacy IT systems and business processes with a fully integrated platform featuring more robust capabilities, greater simplicity and cost efficiency. Prior to this role Mr. Annett was Director R&D Finance at Genentech, and led a group of 16 responsible for a budget in excess of $1 billion supporting the R&D pipeline. Mr. Annett has had extensive experience in entrepreneurial finance and management. He has developed 4 early stage companies, including founding a company, taking it public on NASDAQ and running it for 6 years as CEO. Mr. Annett also played a key role in the turnarounds of four other organizations, three times as Chief Executive. He has served on the Board of Directors of a number of early stage companies.
|
|
| HBC Career Fair 2009 | ||
| Date: | Wednesday October 7, 2009 | |
| Description: | The GSAS Harvard Biotechnology Club proudly presents Career Fair 2009, at the Harvard Medical School.
Date: Wednesday, Oct 7th, 2009 Time: 1.00-5.00PM Venue: New Research Building, Harvard Medical School, 77 Avenue Louis Pasteur, Boston (Google Map) Attending this year's fair are a number of firms representing the sectors of Biotech, Consulting, Patent law and Pharmaceutical. Visit http://www.thebiotechclub.org/careerfair2009/ for list of companies attending. In addition there will be a series of 20 min Presentations by recruiting companies over the afternoon, and a Panel Discussion by various industry leaders on growth opportunities in the biotech industry today, employers' perspectives on what makes an attractive candidate, and suggestions for the transition from academia to industry. *Job applicants/attendees: Please bring resumes/cv's and questions for companies! *For Harvard-affiliated members attending the career fair: please also bring your Harvard ID. *For non-Harvard-affiliated members attending the career fair: we will charge $20 for students and $40 for non-students at the door.
|
|
| Making the Most of the HBC Club's Career Fair: Resumes and Networking | ||
| Date: | Wednesday September 30, 2009 | |
| Description: | Making the Most of the HBC Club's Career Fair: Resumes and Networking
Time: Wednesday, September 30, 2009. 3-4:30 PM Location: Warren Alpert Building, Room 341 *Note: Due to space limitations, the workshops will be given priority to Harvard-affiliated members. Excited about the upcoming Harvard Biotechnology Club Career Fair? To help you prepare for the career fair, Laura Malisheski of the Office of Career Services for Harvard's Faculty of Arts and Sciences, will present this two-part workshop. In part one, we will discuss the conundrum scientists face... when applying for jobs outside academia, should you submit a CV, a resume, or something in between? Learn how to best organize and present your background and experience for different types of PhD-level nonacademic positions. In part two of the workshop, you will learn how to effectively introduce yourself to potential employers and make the most of your time at the HBC Career ! Fair. RSVP: If you would like to attend, please send an email to RSVP@thebiotechclub.org with "workshop" in the subject line. Presented to you by the GSAS Harvard Biotechnology Club (www.thebiotechclub.org) in collaboration with Harvard FAS Office of Career Services- |
|
| Healthcare Consulting Panel Discussion | ||
| Date: | Thursday September 3, 2009 | |
| Description: | Harvard Biotechnology Club and the Consulting Club at MIT
invite you to a Healthcare Consulting Panel Discussion featuring Clarion Healthcare Consulting Clearview Healthcare Partners Decision Resources The Frankel Group Health Advances - Discover career opportunities at the intersection of science, technology, healthcare and business strategy - Unique chance to learn about exclusively healthcare-focused consulting firms and get recruiting tips - Hear from consultants about how healthcare consulting is distinct from other types of consulting Time: Sept 3rd Thursday, 5:30 7:00pm Location: Room 270 Building 3 (Entrance on 77 Massachusetts Avenue) MIT, Cambridge http://whereis.mit.edu/map-jpg?zoom=level2¢erx=710029¢ery=495411&oldzoom=level3&map.x=300&map.y=183 HMS M2 shuttle drops off at 77 Massachusetts Avenue. For M2 shuttle schedule : http://www.masco.org/transit/ptsM2_WeekdaySchedule.htm Registration is not required but highly appreciated. To register and for any questions regarding the event, please email rsvp@thebiotechclub.org Dinner will be provided. Panelist Bios Steven Chao, Partner, ClearView Healthcare Partners Steven has 10 years of experience in life science strategy consulting following MD/PhD program. He was most recently VP of Leerink Swann Strategic Advisors and prior to that a Manager at McKinsey and Company, where he led strategic and operations engagements in pharmaceuticals, biotechnology, and payer organizations. Steven has published over 20 articles, and was involved in Neuroscience research in the laboratories of Dr. Lawrence Benowitz and Dr. Jonathan Seidman. He received his BA in Biochemistry from Harvard College, and M.D. and Ph.D. in Neuroscience from Harvard Medical School. Rob Stolper, Principal, Decision Resources Robert is a Principal with the Consulting group at Decision Resources, where he has extensive experience in pharmaceutical strategy development, product life cycle planning, and market and technology analysis. Mr. Stolper's work includes later-stage clinical development and commercialization opportunity, as well as assessment of innovative drug development strategies, and spans all key therapeutic markets. He recently led an engagement exploring the opportunities and implications of innovative research in cell-based therapeutics for use in academic, commercial, and clinical settings, and developed set of recommendations for a leading global provider of enabling technologies to guide near- and long-term investments. Prior to Decision Resources, Mr. Stolper was a consultant with ISO Healthcare Consulting (part of Monitor Group), where he led product- and franchise-level strategy development engagements. Mr. Stolper received his A.B. in Biochemical Sciences from Harvard University. Pushwaz Virk, Consultant, The Frankel Group Pushwaz joined Frankel Group in 2008 as a Consultant. Since joining, he has worked on a variety of corporate, Technology and Commercialization strategy, Portfolio optimization and L,M&A projects including development of strategy for a Fortune 50 life sciences company to identify, evaluate and invest in early stage technologies, landscape assessment for a biologic in EU, development of M&A strategy for a startup etc. Prior to Frankel Group, Pushwaz was a Management Fellow at Harvard University Health Services and Group Health Plan where he worked on strategic and operational projects in Quality, Finance and Information Technology departments. He also conducted research on international healthcare delivery models at Harvard Business School and developed teaching content on medical tourism. Before joining Harvard, Pushwaz was the Business Development manager at HCL Technologies where he setup the life sciences and healthcare practice of the IT services division and medical process outsourcing business in the BPO division. He practiced as a primary care physician and hospital administrator before moving to the industry. Pushwaz has degree in medicine from Dayanand Medical College India, MBA from University of Delhi, and Masters in Public Health specializing in Healthcare Management from Harvard University. Marie Schiller, Partner, Health Advances Marie joined Health Advances in 1998 with extensive experience in the biotech industry. In Marie's more than one hundred client projects at Health Advances, she has focused on guiding management through business and scientific analyses regarding product development, market positioning, portfolio optimization, business development, and corporate strategy. Prior to joining Health Advances, Marie worked at ArQule, Inc. as production scientist in combinatorial chemistry, synthesis, and production. She also worked for GelSciences, Inc., as project scientist in Polymeric Drug Delivery Systems. Marie contributes extensive expertise in protein-based therapies, drug delivery systems, and several clinical areas, including diabetes and autoimmune diseases. Her clients range from early-stage biotech companies to large pharmaceutical companies. Marie graduated magna cum laude with a BA in chemistry from the University of Vermont, where she was also inducted into the Phi Beta Kappa honor society. |
|
| XSITE 2009: The Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University. | ||
| Date: | Wednesday June 24, 2009 | |
| Description: | High-tech, life-sciences, and energy innovation may well hold the key to the nation's economic health and long-term competitiveness. And as a hotbed of American innovation, New England is poised to become a key driver of economic recovery in the U.S.
This full-day conference will celebrate New England innovation and showcase the panorama of transformative efforts underway in the region in such fields as energy, life sciences, robotics, cloud and mobile computing, and transportation¡Xat universities, startups, and large corporations. At the same time, we plan to challenge New England's innovators to step up and take an even larger role in embracing and shaping the future. XSITE 2009: The Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University Wednesday, June 24, 2009 8:00 am - 7:00 pm SPECIAL BONUSES: The first 50 paid registrants will be invited to a pre-conference party with Xconomy at the Cambridge Brewing Co. on June 10, 5:30-7:30 pm, and will be eligible to win: * a $500 gift certificate to No. 9 Park restaurant, courtesy of Atlas Venture * a 16GB iPod Touch and lunch/iPod tutorial with Xconomy chief correspondent Wade Roush at Legal Seafoods in Kendall Square * breakfast with Xconomy founder and editor in chief Bob Buderi at Henrietta's Table in Harvard Square and signed copies of his three books Register now to get a party invite and a chance at the loot: http://xsite2009.eventbrite.com/ CONFIRMED SPEAKERS INCLUDE: Bob Brown, President, Boston University Juan Enriquez, Managing Director, Excel Medical Ventures John Abele, Co-founder, Boston Scientific Yet-Ming Chiang, Professor of Ceramics, MIT, Co-founder A123Systems Jeff Nick, Senior Vice President, Chief Technology Officer, EMC Mohamad Ali, Massachusetts Senior State Executive, IBM John Maraganore, CEO, Alnylam Reed Sturtevant, Managing Director, Microsoft Startup Labs Christina Lampe-Onnerud, CEO, Boston Power Tillman Gerngross, Co-founder, GlycoFi, Co-founder and CEO, Adimab, Professor of Engineering, Dartmouth Mick Mountz, CEO and Founder, Kiva Systems John D. Halamka, Chief Information Officer, CareGroup Health System, Chief Information Officer and Dean for Technology, Harvard Medical School PRELIMINARY AGENDA: www.xconomy.com/boston/xsite-2009-agenda MORE DETAILS AND LATEST UPDATES: www.XSITE2009.com SCHEDULE: Registration: 7:00 am - 8:00 am Program: 8:00 am - 5:15 pm Networking reception: 5:15 pm - 7:00 pm LOCATION: BU School of Management, 595 Commonwealth Avenue, Boston, MA REGISTRATION INFORMATION: Early Bird Registration (ends June 1): $395 Saver Registration (ends June 15): $495 Regular Registration (ends June 23): $595 On-Site Registration: $650 Student Registration (scholarships available through the Stay in MA program): $95 Press Registration: please e-mail xconomy@schwartz-pr.com Tickets are transferable but not refundable. REGISTER NOW: www.XSITE2009eventbrite.com |
|
| Forefronts in Bioengineering: Stem Cells, Soft Body Robots, Bio-Optics., hosted by ISPE-Boston | |
|---|---|
| Date: | Tuesday June 16, 2009 |
| Description: | On Tuesday, June 16 the ISPE Boston Area Chapter will sponsor an educational program entitled "Forefronts in Bioengineering: Stem Cells, Soft Body Robots, Bio-Optics." The presentation will be followed by a tour of the Advanced Technology Laboratories at Tufts. The program will be held at Tufts Gordon Institute, 200 Boston Avenue, Suite 2400, Medford. A networking reception with hors d'oeuvres will take place before the presentation.
Registration: 5:30-6:00pm. Reception: 5:30-6:30pm. Presentation: 6:30-7:30pm. Tour: 7:30-8:30pm. Members $45; student members $10; non-members $65. To register online, visit www.ISPEboston.org/events/. For further information, Contact the ISPE Boston Area Chapter office at ISPE@camihq.com or 781-647-ISPE(4773). The ISPE Boston Area Chapter is comprised of members from regional life sciences companies as well as service providers and equipment manufacturers that support these manufacturing and research operations. |
| Choosing a lab, hosted by MASS-AWIS and GWIS | |
| Date: | Tuesday June 16, 2009 |
| Description: | Hosted by: AWIS Massachusetts Chapter AND Graduate Women in Science Boston Chapter
Choosing a lab: tips and advice on how to select a graduate or post-doctoral lab and how to get the best out of it once you are there Please join MASS-AWIS and GWIS for a discussion on choosing a graduate and post-doctoral lab. Choosing the right research lab can be one of the most important decisions of a scientist's professional life. Come to learn about the simple rules for selecting the perfect lab and how to get what you want (and need) from Graduate School once you join a lab. Feel free to bring questions for the Q&A session after the presentations. Featured speakers: Joanne Kamens, PhD - Director of Discovery, RXi Pharmaceuticals, Worcester, MA Sharotka Simon, PhD ¡V Post-doctoral fellow, Brandeis University, M When: Tuesday, June 16, 2009, 5:30pm ¡V 8:30pm Where: Harvard School of Dental Medicine, Research and Education Building 190 Longwood Avenue, BOSTON, MA 02115 (http://www.hsdm.harvard.edu/asp-html/) Opportunity for networking with our speakers & Refreshments will be served FOR DIRECTIONS AND MORE INFORMATION, REGISTER BEFORE JUNE 11 AT http://www.acteva.com/booking.cfm?bevaid=182421 $5 for members and students - $10 for non-members Join AWIS and/or GWIS to save money on events and to support our work! Go to www.mass-awis.org, www.gwisboston.org, or pick-up a membership form at the event. |
| Massachusetts Life Sciences Innovation Day | |
| Date: | Wednesday June 3, 2009 |
| Description: | Massachusetts Life Sciences Innovation Day
"The Survival of the Fittest Life Sciences Companies" How to survive in the current environment, discover new innovations, identify new markets and raise financing for great products and startups in life sciences in Massachusetts June 3, 2009 8:00 a.m. - 6:00 p.m. Sheraton Boston Hotel The 2nd Massachusetts Life Sciences Innovation Day is the biggest day for life sciences startups and innovation in the State of Massachusetts. Last year this house-full, high-energy, hands-on event brought together legendary speakers and experts to mingle with innovators, post-docs, professors, entrepreneurs, innovators, and venture capitalists. It is the flagship event of life sciences in Massachusetts, jointly and actively put together by all the major organizations that are involved in starting the life sciences startup ecosystem in the Commonwealth. 2009 is the 150th anniversary of the publication of Charles Darwin's On the Origin of Species. As we hope to show you in this program Darwin's theory of evolution may be applied to business and technology development. Alnylam, Genzyme, BiogenIdec, Boston Scientific, Sirtris and Confluent are all companies that have evolved to become major players in the Massachusetts life sciences industry. They all started as basic science theories - in a nurturing environment and with the work of many scientists, engineers and business executives these ideas became new products that have changed global healthcare. At this event we'll talk about how to survive and thrive in both academic and industry research and how to see your ideas be transformed into new products. We'll look at how to Raise money... Change cultures... Chase the best ideas, as well as get a wi! ndow on the future of what's new. We have an exciting program: · Listen to fascinating keynote speeches and panels · Walk around the Innovator's Marketplace where you will find everything you need to start a billion dollar life sciences company · Meet inventors and entrepreneurs at the poster presentations · Listen to captivating never-before-discussed panels on the "The Sociobiology of Life Science Cultures" and "Proof of Concept: The Missing Link" where all startup related challenges are explored · Celebrate the 150th anniversary of "On The Origin of Species" by Charles Darwin" by attending "The Natural Selection of Life Science Start-ups" and "The Evolution of Life Science Technologies" · Learn from the industry's top investors at the panel "Have the Rules of Getting Investment Changed?" · Network with the Who's Who of Massachusetts life sciences. Every major stakeholder in the Commonwealth in life sciences is involved in jointly organizing this event - including the major universities, research centers and hospitals WHO SHOULD ATTEND? Everyone involved in the life sciences innovation and entrepreneurship ecosystem of MA should attend. This event is designed to inspire researchers, innovators, entrepreneurs, post-docs and graduate students throughout the Commonwealth to take their ideas to commercialization faster - whether it is through management, funding or partnerships. It is an opportunity to meet serial entrepreneurs, venture capitalists, angel investors as well as many top leaders who have created companies or commercialized technologies coming out of laboratories and ideas. The day's event will bring together the Commonwealth's leading researchers and innovators, along with top-tier management of biotech, pharma and medtech companies as well as the key life sciences funding sources including angels, foundations, venture capitalists, grant experts, Federal Government and philanthropists. WHO WILL YOU MEET? The day's events will bring together the Commonwealth's leading researchers and innovators, along with top-tier management of biotech, pharma and medtech companies and the key life sciences funding sources including angels, foundations, venture capitalists, grant experts, Federal Government representatives, state elected officials, state program managers, and philanthropists focused on cures. We'll supplement this high-octane group with consultants, lawyers and sector experts who can help you find answers faster. CONFERENCE FEES $180 Academics/staff at MATTO member institutions, and Members of MATTO, MBC, Mass MEDIC, TiE, MIT Enterprise Forum, and OPEN. $225 Non-members $50 Students and post-docs (ID's will be required at the event) Research Showcase Poster Presenter - have to apply to present and pay Conference registration fees. Download Poster Presenter Application from the website: http://www.mattcenter.org/malsid2009/home.html $500 - Innovators' Marketplace Exhibitor (includes two attendees). Service providers will only be allocated space in the exhibit hall if they sponsor the conference - for a listing of sponsorship opportunities please visit our Sponsorship page: http://www.mattcenter.org/malsid2009/sponsorship.html FOR MORE INFORMATION: Conference Information: http://www.mattcenter.org/malsid2009/home.html TO REGISTER: Conference Registration: http://register.donahue.umassp.edu/events/one?event%5fid=115949 FOR SPONSORSHIP OPPORTUNITIES Contact : Abi Barrow, MTTC, at abarrow@umassp.edu Anupendra Sharma, TiE, at anupendra@yahoo.com FOR INNOVATORS' MARKETPLACE: Contact: Pushwaz Virk, Frankel Group, at pushwaz@gmail.com ABOUT MALSI Massachusetts Life Sciences Innovation Day has been developed by the Massachusetts Life Sciences Start-up Initiative (MALSI). MALSI is a platform organization that brings together all major public and private entities in the State that are committed to building the next generation of Massachusetts companies. MALSI's mission is to ensure that Massachusetts maintains its lead as the #1 region in the world to start, nurture and grow life sciences companies. MALSI partners include: Massachusetts Technology Transfer Center, the Massachusetts Biotechnology Council, MassMEDIC, TiE Boston, and several major universities and research hospitals. |
| Annual Women in Biotech Panel Discussion | |
| Date: | Monday June 1, 2009 |
| Description: | Harvard Biotechnology Club
presents The Annual Women in Biotechnology Event Come and meet distinquished women leaders in the biotech industry and learn about their path to success, what they have learned, and how they have balanced their personal lives with their careers. Our stellar group of panelists includes a venture capitalist, patent lawyer, and executive leaders from biotech/pharma companies. Panelists Ellen Baron (Partner, Oxford Biosciences) Carmen Bozic (Vice President, Biogen Idec) Pamela Stetkiewicz (Executive Director, Novartis) Ivana Magovcevic-Liebisch (Executive Vice President, Dyax Pharmaceuticals) Moderated by Pearl Freier, President of Cambridge Biopartners Refreshments will be served. Men are invited and encouraged to attend! This event is free for all Harvard students and Harvard/Harvard hospital affiliated postdoctoral fellows. For non-Harvard affiliated attendees, registration is $10 to be paid at the door To register - rsvp@thebiotechclub.org Visit our website for more event information www.thebiotechclub.org |
| INTELLECTUAL PROPERTY & PATENT LAW PANEL DISCUSSION | |
| Date: | Wednesday April 22, 2009 |
| Description: |
THE HARVARD BIOTECHNOLOGY CLUB Presents INTELLECTUAL PROPERTY & PATENT LAW PANEL DISCUSSION April 22 (Wed), 2009 5:30-7:00 PM Bray Room, New Research Building, Harvard Medical School, 77 Ave Louis Pasteur, Boston, MA 02115 Panel 1: Navigating the licensing and patent hurdles involved in bringing a technology to the marketplace. Pamela D. Ariniello Associate General Counsel for Intellectual Property Dana-Farber Cancer Institute Vivien J. Tannoch-Magin, Ph.D. Associate Hamilton, Brook, Smith & Reynolds, P.C. Panel 2: Patent Law as a career option for Scientists. Melissa Hunter-Ensor, Ph.D. Associate Edwards Angell Palmer & Dodge LLP Brenda Danek, Ph.D. Associate Finnegan PIZZA AND DRINKS WILL BE SERVED *OPEN TO HARVARD AFFILIATED MEMBERS* Questions? Please email shaila@thebiotechclub.org or visit our website, www.thebiotechclub.org |
| Harvard Asia Business Conference | |
| Date: | Saturday February 14, 2009 |
| Description: | There will be a Healthcare Panel at the conference, focusing on how Asia can differentiate itself in biotech/pharma/healthcare industries, which may be of interest to you. The moderator & speakers include the following: Stephen Knight, Managing Director of Fidelity Biosciences (US; moderator); Sam Liao, Head of Business Development & Licensing, Asia of Novartis Vaccines & Diagnostics; Tomoko Ohmae, CEO of PRARD Inc. (Japan); Chi-Huey Wong, President of Academia Sinica (Taiwan).
Additionally, there will be biotech/pharma-focused speakers in other panels, including in the Entrpreneurship panel and the VC panel. It is a good opportunity to get to know the biotech/pharma trend of Asia, as well as how this industry interacts with the Asian governments as well as other for- and non-profit businesses. For all Harvard students and affiliates including postdocs, fellows, and residents: please register for student rate (see below). Please remember to bring your Harvard ID to the conference. ***************** The Executive Committee of the Asia Business Conference organized by the Harvard Business School, Harvard Law School, and the Harvard Kennedy School of Government would like to invite future leaders who will make an impact in Asia and the rest of the world to this year's conference. Spanning over 2 days, this yearâs conference will be held at the Harvard Business School in Boston on February 14-15, and will feature many leaders in business, government, and the public sector. For participants, the conference will offer unique networking opportunities through a variety of scheduled events. Please visit www.asiabusinessconference.org for more information and registration details. We look forward to meeting you at the conference. |
| The 6th annual Healthcare Conference | |
| Date: | Saturday January 17, 2009 |
| Description: | 6th Annual Healthcare Conference, hosted by the HBS Healthcare Club "Changing Times, Endless Opportunities: Healthcare Innovation, Policy, and Financing." January 17, 2009
SAVE THE DATE! The 6th annual Healthcare Conference: "Changing Times, Endless Opportunities: Healthcare Innovation, Policy, and Financing" Saturday, January 17, 2009 Harvard Business School Please join us for the 6th Annual Healthcare Conference, presented by the Healthcare Club, Student Clubs of HBS. Panel topics include venture capital and entrepreneurship, phama/biotech, medical device, payor/provider, personalized medicine, and public health/public policy. Our featured keynote speakers include: Ron Williams, CEO of Aetna Scott Gottlieb, Former FDA Deputy Commissioner Lonnie Smith, CEO of Intuitive Surgical Registration available December 2nd at: Healthcare Conference Registration. Thank you, and we look forward to seeing you in January! Sincerely, Joanne Chang & Kristin Myers, Conference Co-Chairs |
| MIT Enterprise Forum Innovation Series. | |
| Date: | Wednesday November 12, 2008 |
| Description: | MIT Enterprise Forum Innovation Series. November 12th.
When: Wednesday, November 12th from 6 to 8:30 PM Where: MIT Stata Building Kirsch Auditorium Students are free with ID Pre-registration is encouraged http://www.mitforumcambridge.org/nov.html Neuroscience Drug Discovery and Development: The Route to Disease-Modifying Therapies Disorders of the brain, including neurodegenerative diseases such as Alzheimers and Parkinsons disease and psychiatric diseases such as schizophrenia and depression, pose some of the hardest challenges for the biopharmaceutical industry. Join us for a discussion of how the biopharmaceutical industry is addressing these challenges, with guest speakers from the cutting edge of neuroscience drug discovery. Speakers: Darryle D. Schoepp, Ph.D., Senior Vice President and Neuroscience Franchise Head, Merck Research Laboratories Christoph M. Adams, Ph.D., Chief Business Officer, FoldRx Pharmaecuticals, Inc. Douglas M. Fambrough, Ph.D., General Partner, Oxford Bioscience Partners Todd Sherer, Ph.D., Vice President Research Programs, The Michael J. Fox Foundation for Parkinsons Research Moderator: Skip Irving, Partner and Managing Director, Health Advances LLC http://www.mitforumcambridge.org/nov.html Contact person: Regina Young, reginas@mit.edu |
| Harvard Biotechnology Club Annual Career Fair | |
| Date: | Tuesday November 11, 2008 |
| Description: | Are you curious about career options outside of academia?
Are you currently looking for a job? Harvard Biotechnology Club presents 2008 Career Fair November 11th, 1-5pm 3rd Floor Rotunda, New Research Building, HMS Rotunda, NRB (3rd floor) 1:00 - 5:00pm: Recruiting tables The career fair features biotech, pharmaceutical, patent law, investment and consulting firms. Firms are looking to recruit applicants with doctoral/medical (PhD, MD, MPH, postdoctoral fellows, residents) and other healthcare/life science degrees. Applicants are encouraged to bring their resumes. Even if you arenât on the job market come find out more about potential career paths. Room 217, NRB (2nd floor) 4:00 - 5:00pm: Panel discussion: Exploring Alternative Career Paths in Industry For Scientists Panelists: Roopom Banerjee: Vice President, Leerink Swann & Company, Inc. Michael J. Belliveau, Ph.D., Partner, Clark & Elbing, LLP Mike DeRidder, Ph.D., consultant, LEK Consulting Emily Walsh, Ph.D., Program Manager, Alnylam Pharmaceuticals Join our speakers in an engaging discussion about career opportunities in industry outside the bench and gain insight into their career paths in consulting, program management, investment banking and law. Moderated by Pearl Freier of Cambridge BioPartners *** No registration or RSVP is required for attending the career fair. For Harvard-affiliated/HMS affiliated hospital members attending the career fair: Please bring your Harvard/Hospital ID. For non-Harvard-affiliated members attending the career fair: we will charge $10.00 at the door. For questions, please email us : careerfair@thebiotechclub.org For more information and list of attending companies, please visit: www.thebiotechclub.org/careerfair2008 |
| Panel discussion: Exploring Alternative Career Paths in Industry For Scientists | |
| Date: | Tuesday November 11, 2008 |
| Description: | Curious about careers in science outside the bench?
Panel discussion: Exploring Alternative Career Paths in Industry For Scientists November 11th (Tomorrow) 4:00 - 5:00 pm : Room 217 NRB Join speakers from the biotech industry in an engaging discussion about career opportunities in industry outside the bench and gain insight into their career paths in consulting, program management, investment banking and law. Panelists: Roopom Banerjee: Vice President, Leerink Swann & Company, Inc. Michael J. Belliveau, Ph.D., Partner, Clark & Elbing, LLP Mike DeRidder, Ph.D., consultant, LEK Consulting Emily Walsh, Ph.D., Program Manager, Alnylam Pharmaceuticals Moderated by Pearl Freier of Cambridge BioPartners Hosted by GSAS Harvard Biotech Club: www.thebiotechclub.org |
| 2008 Life Sciences & Healthcare Venture Summit, hosted by the YoungStartup Ventures. | |
| Date: | Thursday October 30, 2008 |
| Description: | YoungStartup Ventures will be hosting the 2008 Life Sciences & Healthcare Venture Summit on October 30th, 2008 at Digital Sandbox in New York City.
This exclusive summit will bring together over 350 VCs, Private Investors, Corporate VCs and CEOs of emerging companies. The event will feature 30 Top VCs on interactive panels; 48 cutting edge CEO presentations, and high-level networking opportunities. Members from the Harvard Biotechnology Club can receive a 10% discount at this event. Please email Joe Benjamin at joe@youngstartup.com to request for ticket discount and indicate that you are a member of the club. Link to the 2008 website: http://www.youngstartup.com/lifesciences08/index.php |
| Harvard Biotechnology Club's Power Career Workshop, Oct 30th (Thursday), 2008, 2:30-4:30pm | |
| Date: | Thursday October 30, 2008 |
| Description: | Harvard Biotechnology Club's Power Career Workshop, Oct 30th (Thursday), 2008, 2:30-4:30pm
Excited about the upcoming Harvard Biotechnology Club Career Fair? To help you prepare for the Harvard Biotech Club Career Fair on November 11, 2008, Laura Malisheski of the Office of Career Services for Harvard's Faculty of Arts and Sciences, will present two workshops: CV, Resume, or Something In-Between? Scientists applying for jobs outside academia are faced with a conundrum... should you submit an academic CV, a one-page resume, or a hybrid of the two? Come to this workshop to learn how best to organize and present your background and experience for different types of PhD-level nonacademic positions. Thursday October 30 2:30-3:30pm Warren Alpert Building 341 Networking at the HBC 2008 Career Fair Not everyone likes to network, but most everyone recognizes that it's an essential part of landing a fantastic job! Come to this workshop to learn how to effectively introduce yourself to potential employers and make the most of the HBC 2008 Career Fair. Thursday October 30 3:30-4:30pm Warren Alpert Building 341 RSVP: If you would like to attend either or both of these events, please send an email to RSVP@thebiotechclub.org with "workshop" in the subject line. Presented to you by the GSAS Harvard Biotech Club www.thebiotechclub.org in collaboration with Harvard FAS Office of Career Services |
| Moving Your Career Forward in the Biotech and Pharmaceutical Industries | |
| Date: | Monday October 27, 2008 |
| Description: | Moving Your Career Forward in the Biotech and Pharmaceutical Industries This panel discussion will include scientific leaders and human resources staffing executives from companies including Alnylam, Genzyme, Sirtris, and Vertex Pharmaceuticals to discuss growth opportunities in the industry, employers' perspectives on what makes an attractive candidate, and suggestions for transitioning from academia to industry. Q&A period with the audience to follow the discussion .
*Please note only pre-registered candidates are invited to attend. Please bring your confirmation number with you to the career fair before 12:30pm to attend. Space is limited, so please arrive early to ensure your attendance. Confirmed panelists: Rachel Meyers, PhD, Senior Director of RNAi Lead Development, Alnylam Pharmaceuticals Carolyn Churcher, Senior Director Strategic Staffing, Genzyme Corporation Brian M. Gallagher, Jr. PhD, Director of Strategic Development, Sirtris, a GSK company Lisa Anderson, Senior Director Strategic Staffing, Vertex Pharmaceuticals For more information, please visit http://www.biospace.com/jobs/career-fair-detail/?CareerFairId=159 Moderated by: Pearl Freier, Cambridge BioPartners Contact person: June Salvati, customercare@biospace.com |
| Harvard Biogen Idec Day | |
|---|---|
| Date: | Monday October 20, 2008 |
| Description: | Harvard Biogen Idec Day, Monday October 20th 2008
Ever wondered what it would be like to work for a biotech company? This is your chance to explore the exciting world of biotechnology and learn more about one of the global leaders in the biotech industry. Founded in 1978, Biogen Idec is a key player in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that treat diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Event Details Date - Oct 20th, 2008 Time - 12pm - 3pm Location - Bray Room & Pechet Room - New Research Building, Harvard Medical School 41 Avenue Louis Pasteur, Boston 02115 Biogen Idec Genetown Cafe - Building 6 12 Cambridge Center Cambridge Schedule 12pm-12:45pm : Keynote speech by Al Sandrock (Senior Vice President, Biogen Idec) The keynote speech will address topics such as what is a Biotech company? Biogen Idec's product pipeline, and an overview of therapeutic research areas at Biogen Idec. 12:45pm-1:30pm : Informal networking lunch Representatives from Biogen Idec Talent Acquisition group will be present to answer questions. 1:30pm-3pm : Panel Discussion with Q&A led by Ken Rhodes (Vice President, Biogen Idec) The interactive panel discussion will focus on topics related to careers in biotech including diversity of job opportunities in biotech, skills that prospective employers are looking for in applicants and the contrast between careers in academia and industry. Panel participants will be a mix of seasoned and junior Biogen Idec scientists. 4pm-5pm : Biogen Idec Onsite - Networking Cocktail Hour sponsored by Biogen Idec University Relations Location - Genetown Cafe (Building 6) - 12 Cambridge Center, Cambridge Don't miss out on this unique opportunity to visit the Biogen Idec campus and interact with Biogen Idec employees including Harvard alums! There are limited spaces for the event please RSVP at RSVP@thebiotechclub.org with the subject "Biogen Idec" indicating whether you would like to attend the HMS event, the Biogen Idec onsite event, or both. Please include your name, affiliation and position. Priority for the Networking Cocktail Hour at Biogen Idec facilities will be given to Harvard-affiliated participants. Presented to you by the GSAS Harvard Biotech Club www.thebiotechclub.org |
| Worcester Polytechnic Institute Venture Forum: $15K Technology Business Plan Contest | |
| Date: | Friday October 10, 2008 |
| Description: | Are you starting a technology-based business
and could use some advice? Are you interested in polishing your presentation skills in front of a panel of potential investors? What about a chance to win $15,000 or more in cash and professional services? If you said yes to any of these questions, then enter the WPI Venture Forum Annual Business Plan Contest. The WPI Venture Forum Business Plan Contest is open to any technology-based pre-start, startup, and on-going businesses located in the Northeast. Students are welcome. WPI Venture Forum $15K Business Plan Contest entry form and info: www.wpiventureforum.org Deadline Submissions: Friday, October 10, 2008. There is a $50 entry fee. |
| The ISPE Boston Area Chapter presents 2008 Product Show | |
| Date: | Wednesday October 8, 2008 |
| Description: | The ISPE Boston Area Chapter presents its 2008 Product Show from 12 noon to 8pm at the Gillette Stadium Clubhouse in Foxboro, MA. This event is the biggest one-day gathering of biotech, pharmaceutical and life sciences professionals in the northeast and features educational sessions, 250 exhibitors, career fair, behind-the-scenes tours of the stadium, unlimited networking opportunities, student chapter meeting and a chance to meet special guest, pro football Hall of Famer and former Patriot great, John Hannah. The event - including parking and refreshments - is free for all attendees. For more information and to register online, visit http://www.ispeboston.org/ or call 781 647 ISPE (4773).
The ISPE Boston Area Chapter is comprised of over 1,300 members from regional biopharmaceutical companies as well as service providers and equipment manufacturers that support these manufacturing and research operations. Should you have any questions, please feel free to contact the ISPE Boston Area Chapter office at ISPE@camihq.com or 781-647-ISPE(4773). |
| StartUp Opportunities in Life Sciences by Lyon Area Economic Development Agency (ADERLY) | |
| Date: | Tuesday September 23, 2008 |
| Description: | Join us at the workshop : "StartUp Opportunities in Life Sciences" on Tuesday September 23, 6:30pm
For the full program and to register, or print the invitation attached to this email: http://www.adgensite-emailing.com/aderly/newsletters/archives/tests/46/2008-07-25_15-39-41.html. Meet with entrepreneurs, business coaches, representatives of the Lyon bio-cluster to : - Figure out why and how to start a Tech Venture between the US and France/Europe, - Get some testimonials by French-American bio entrepreneurs, - Identify why Lyon ranks #1 in Life Sciences, - Boost your start-up project with partners, resources and funding opportunities. - A networking cocktail will follow the workshop. Hosted at the Genzyme Center, 500 Kendall St, Cambridge on tuesday September 23, from 6:30 to 8:30pm. Presented by the Lyon Area Economic Development Agency (ADERLY), with the support of the French-American Chamber of Commerce (FACCNE) and the Young Entrepreneurs Initiative (YEi). |
| Xconomy Forum: How to Build a Life Sciences Company | |
| Date: | Tuesday September 23, 2008 |
| Description: |
For more information: http://www.xconomy.com/boston/2008/08/19/xconomy-forum-how-to-build-a-life-sciences-company/ Everybody knows that the IPO market is in the doldrums, and that biotechnology and pharmaceutical companies are having their worst year in some 24 years when it comes to developing new drugs. But innovation is messy--and often the best innovations spring from hard times. Today's difficult fund-raising and competitive climate requires creative and flexible approaches to building and sustaining a life sciences company, whether it be in biotech, diagnostics, medical devices, or some other aspect of health care. This conference and networking event features case studies and from-the-trenches stories of new models of innovation---including novel types of collaboration, venture philanthropy, and new approaches to incubation. So, come learn what leading entrepreneurs and life sciences companies are doing to build the next generation of great life sciences companies. |
| Tech Square Block Party- hosted by New Scientist | |
| Date: | Thursday September 18, 2008 |
| Description: | New Scientist is hosting a block party for all to attend particularly geared towards those interested in science and technology. Free food and drinks will be served, and the event will offer science pub trivia, a wii tournament, prizes and giveaways, and the opportunity to network with local science lovers.
More event information can be found at www.tinyurl.com/TechSquareBlockParty. The event is sponsored by Alexandria Real Estate, Charles River Labs, Novartis and Pfizer. |
| McKinsey & Company presentation at Harvard, September 18, 2008 | |
| Date: | Thursday September 18, 2008 |
| Description: | For Ph.D. students, Post-docs, M.D. students, Interns, Residents, Fellows and Masters students (non-M.B.A.)
*Please note that Masters students should have completed their undergraduate degree before July 1, 2005. If you completed your undergraduate degree after this date, visit www.mckinsey.com/usschools to learn more about our Business Analyst opportunities. Date: Thursday, September 18, 2008 Time: 6:00 pm - 8:00 pm Location: Sheraton Commander (George Washington Ballroom), 16 Garden Street, Cambridge, MA, 02138 Campus Map: http://www.mapquest.com/maps?address=16+Garden+Street%2C+Cambridge%2C+MA%2C+02138 Presentation Agenda: 6:00 - 6:30 pm Introduction to McKinsey and our work, overview of recruiting steps 6:30 - 6:45 pm Group Q&A 6:45 - 8:00 pm Reception, McKinsey consultants available for small group and individual discussions (refreshments served) ABOUT MCKINSEY & COMPANY, AND THE HEALTHCARE PRACTICE: McKinsey and Company is a global management consulting firm with 89 offices in 45 different countries. We work for 93 of the global Fortune 100 companies, 70 of the US Fortune 100 companies, and over 2000 governments, NGOs, and non-profits across a wide variety of industries, functions, and geographies. About half of McKinsey consultants come from non-business backgrounds, and about half of those are MDs or PhDs. Currently, there are over 850 healthcare-focused consultants at McKinsey, twice as many as 10 years ago. Within healthcare, our work is extremely diverse in nature and ranges from developing pre-clinical drug discovery strategies for biotechnology and pharmaceutical companies, to helping global non-profits and state governments develop their strategic approach to health crises, to helping large medical centers develop best-in-class clinical quality systems. Our work is global in nature with projects taking place in offices across North America, Asia, the Middle East and Europe. Consultants often find that they have the opportunity to do work in healthcare in countries outside of the United States if they wish. Healthcare clients we work with include: l Global public health entities: Major non-governmental organizations (e.g., The World Health Organization, The Bill and Melinda Gates Foundation, the Clinton Global Initiative, the United Nations), national governments (including China, UK, , leading public health foundations l Payor/providers: 20 leading academic medical centers, 7 of the 10 largest US hospital systems, governments (e.g., National Health System in the UK), major pharmacy benefit managers,! and 8 of the top 10 managed care systems l Private equity funds: 19 of 20 top U.S. private equity firms. Participated in 9 of the top 10 European and 7 of the top 10 U.S. buyout deals since in 2006 l Pharmaceutical, Biotechnology, Device and Diagnostic Companies: 19 of the 20 largest pharmaceutical companies. Most of the major biotechnology, device and diagnostic companies APPLICATION DEADLINE Application deadline for permanent positions in offices worldwide: September 28, 2008. Please visit our website for more information and to apply: www.apd.mckinsey.com If you will be finished with your studies in 2009 you should apply for a permanent position by the deadline above. Medical interns, residents and fellows finishing in 2010 may also apply now, for a permanent position, to receive an early decision. Those finishing studies in 2010 may apply for an internship by December 7, 2008. All others finishing their program at a later date are welcome to attend and learn more for the future. If you will not be applying now, you may register at the same website; registrants will receive e-mails about upcoming events and opportunities. Please contact your recruiter should you have questions: Anu Priyadarshi, Recruiter McKinsey & Company anu_priyadarshi@mckinsey.com www.apd.mckinsey.com |